Date | Insider | Price | Amount |
---|---|---|---|
8-18-2021 Insider Buy |
Clay Thorp Director |
$3.00 CAGR » |
$30,000.00 10,000 shares |
12-10-2018 Insider Buy |
Jonathan P. Mow Chief Executive Officer |
$3.87 CAGR » |
$5,803.00 1,500 shares |
12-4-2018 Insider Buy |
Clay Thorp Director and >10% Owner |
$3.13 CAGR » |
$12,520.00 4,000 shares |
10-22-2018 Insider Buy |
Plc Astrazeneca >10% Owner |
$5.00 CAGR » |
$3,000,000.00 600,000 shares |
10-22-2018 Insider Buy |
Enterprise Associates 13 LP New >10% Owner |
$5.00 CAGR » |
$9,000,000.00 1,800,000 shares |
Also See: Institutional Holders of PHAS
Also See: SEC filings
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 08/19/2021 | |
End date: | 11/02/2022 | |
Start price/share: | $3.14 | |
End price/share: | $0.07 | |
Dividends collected/share: | $0.00 | |
Total return: | -97.77% | |
Average Annual Total Return: | -95.74% | |
Starting investment: | $10,000.00 | |
Ending investment: | $222.73 | |
Years: | 1.21 |
PHAS Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent PHAS insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding PHAS
Free PHAS Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Other companies seeing insider buying close in time to when the PHAS Insider Buying occurred are:
TWTR Insider Buying |